Since the introduction of robotic systems in esophageal surgery in 2000, the number of robotic esophagectomies has been gradually increasing worldwide, although Thus, the merits or demerits of robotic surgery in this field remain quite difficult to assess. However, in the near future, the merits will definitely outweigh the demerits because the esophagus is an ideal organ for a robotic approach.
was carried out by Horgan et al. 4 in September 2001 at the University of Illinois, Chicago. Horgan's procedure was a transhiatal esophagectomy (THE). Robotic transthoracic radical esophagolymphadenectomy (a type of TTE) was first done in November 2002 at the University of Iowa Hospital, Iowa City, and reported by Kernstine et al. 5 Initially, the potential advantages of this technological innovation were thought to allow surgeons to carry out more precise and safer, more minimally invasive procedures, compared with conventional laparoscopic procedures. 6 Also, the esophagus was regarded as an ideal organ for a robotic approach, 7 because the esophagus is anatomically located in a limited and narrow space, the mediastinum, behind such vital organs as the heart and the trachea. Figure 1 shows growth in the number of robotic esophagectomy procedures using the da Vinci system around the world. Although the numbers are gradually increasing worldwide, robotic esophagectomy for esophageal cancer is not yet regarded as a standard procedure, or as superior for treatment of urological and gynecological malignancies because of the lack of clear benefits. 8 Robotic surgery's advantages and disadvantages for esophageal cancer thus remain controversial.
We reviewed this problem focusing on robotic surgery for esophageal carcinoma, although high-level evidence is lacking because of the absence of any except currently ongoing randomized controlled trials. 9 
| EARLY RESULTS WITH SMALL SE RIES OF TRANSH IATAL E SOPHAGECTOMY
Initial small series of reports on transhiatal esophagectomy (THE) are reviewed here. A total of three such papers have been published. [10] [11] [12] Respectively, numbers of patients were 18, 23, and 40; mean operative time, estimated blood loss, hospital stay, and lymph node yield were 279 min (231-311), 88 mL (54-100), 9.2 days (9-10), and 17 (14) (15) (16) (17) (18) (19) (20) .
Robotic THE was reported to be safe even after chemoradiotherapy.
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These reports showed high complication rates, approximately 50%; one patient (1/81, 1.2%) died from pulmonary failure after surgery. Table 1 summarizes the surgical outcomes of these series. One paper reported a high incidence (19.4%, 7/36) of incarcerated hiatal hernia after robotic THE. 13 Indications for robotic THE were mostly adenocarcinomas located in the distal esophagus and gastroesophageal junctions. 
| LEARN ING CURVE
Some papers focused on the learning curve with robotic surgery.
Robotic console time with this innovative procedure was reported to be significantly reduced after the initial six patients. 22 A significant reduction in total operative time was identified after the initial 20 or 30 cases.
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| AFTER THE INITIAL SERIES
To the best of our knowledge, very few or no series of robotic THE have been published following the initial small series; more results of
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robotic TTE, albeit few, have been published. [29] [30] [31] [32] Surgeons still disagree over the relative merits of THE versus TTE. One paper reported seriously high morbidity in both groups. 33 Another paper reported that TTE achieved a higher rate of R0 resections, a higher lymph node yield, and resulted in longer survival than THE, especially in advanced cases. 34 Therefore, TTE is putatively more radical and therefore a more definitive treatment for esophageal cancer. 25 reported that robotic assistance significantly reduced the incidence of recurrent laryngeal nerve palsy and hoarseness. Park et al. 44 reported that the total number of dissected lymph nodes was significantly greater in the robotic than in the thoracoscopic groups, especially in the upper mediastinum and abdomen.
| REVIEW ARTICLES
Several published review articles have focused on robotic esophagectomy. 8, [45] [46] [47] All of them acknowledge the technical superiority of robotic surgery (ie a three-dimensional view with up to 10-fold magnification, articulated instruments with seven degrees of movement, natural hand-eye coordination axis, and tremor filter).
The longer operative time was pointed out as a disadvantage. The most important concern is that high-level evidence of robotic esophagectomy's superiority is lacking, despite technical, oncological, and safety advantages over conventional procedures. One reason is that no randomized controlled trial of sufficient size has been conducted to show any clear benefit. Another problem is cost. Some benefit must be shown to outweigh the higher cost. The combination of fluorescence, overlay, or other advanced diagnostic imaging with robotic procedures has additional potential benefits. To conclude, robotically assisted meticulously executed procedures are expected to reduce the development of complications and improve the radicality of lymphadenectomy, which will translate into good short-and long-term outcomes.
| NOVEL PROCEDURES
With the aim of averting postoperative pulmonary complications without diminishing lymphadenectomy (ie aiming at equivalence to the transthoracic approach), a nontransthoracic radical esophagectomy procedure has been developed which combines a video-assisted cervical approach for the upper mediastinum (Figure 2A) and a robot-assisted transhiatal approach for the middle ( Figure 2B ) and lower mediastinum. 48, 49 The 
| COMMEN TS
No-one denies the technical innovativeness and advantages of robotic surgery, and the anatomical features of the esophagus make it an ideal organ for robotic surgery. Robotic surgery therefore has merits for esophageal cancer, but it is still not regarded as a standard procedure, as a result of the paucity of definite high-level evidence and its unacceptably high cost. We must wait for the results of ongoing randomized controlled trials to be reported 9 and look forward to seeing competition leading to lower costs. Meanwhile, continuous endeavors to identify and develop additional areas of progress in the technology such as epochal imaging systems or TME applying the strong points of robots are crucial for academic surgeons pioneering the use of robotic systems. 
